PFM Health Sciences’s Compass Pathways CMPS Stock Holding History
Bought
Maintained
Sold
Other funds holding CMPS
DTC
RI
BC
TCM
AIM
LGM
EHI
PFM Health Sciences's CMPS Position: Q2 2026 in Review
PFM Health Sciences reduced its Compass Pathways (CMPS) stake by 82% in Q2 2026, selling an estimated $11.4M and leaving 247,589 shares worth $3.5M. The position accounts for 0.3% of the portfolio, ranked #79.
PFM Health Sciences first reported a position in CMPS in Q2 2022 and has held it in 17 quarters since. The position peaked at $9.53M in Q3 2025. 223 funds tracked by Wall St. Rank hold CMPS as of Q2 2026.
- PFM Health Sciences held 247,589 shares of Compass Pathways worth $3.5M as of Q2 2026.
- PFM Health Sciences sold 1,119,510 Compass Pathways shares in Q2 2026, an estimated $11.4M.
- Compass Pathways made up 0.3% of PFM Health Sciences's portfolio in Q2 2026, its #79 holding.
- PFM Health Sciences first reported a position in Compass Pathways in Q2 2022 and has held it in 17 quarters since.
- PFM Health Sciences's Compass Pathways position peaked at $9.53M in Q3 2025.
- 223 funds tracked by Wall St. Rank held Compass Pathways as of Q2 2026.
Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.